Dr. Daniel Getts is an energetic executive focused on translating cutting edge scientific breakthroughs into meaningful medical therapies. Placing himself at the center of the academic/industry interface Dr. Getts uniquely melds his business, pathology, inflammation and immunology understanding to identify value creating strategic biotechnology product development opportunities.
Dr. Getts also holds a visiting positions at Northwestern University & The University of Sydney and is Deputy Editor of Cellular Immunology. He has over fifty patents / applications and has published his academic work in top tier scientific journals including Nature Biotechnology, Science Translational Medicine, ...